Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens

被引：10
|
作者：
Jain, Preetesh [1 ]
Kantarjian, Hagop [1 ]
Jain, Nitin [1 ]
Short, Nicholas J. [1 ]
Yin, Cameron C. [2 ]
Kanagal-Shamanna, Rashmi [2 ]
Khoury, Joseph [2 ]
Konopleva, Marina [1 ]
Sasaki, Koji [1 ]
Kadia, Tapan M. [1 ]
Garris, Rebecca [1 ]
Pierce, Sherry [1 ]
Estrov, Zeev [1 ]
Wierda, William [1 ]
Cortes, Jorge [1 ]
O'Brien, Susan [3 ]
Ravandi, Farhad [1 ]
Jabbour, Elias [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 10期
关键词：
THERAPY;
D O I：
10.1002/ajh.24833
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E595 / E597
页数：4
相关论文
共 50 条
  • [1] Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma
    Abaza, Yasmin
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Thomas, Deborah A.
    Kadia, Tapan M.
    Borthakur, Gautam
    Burger, Jan
    Wierda, William G.
    Jain, Nitin
    Faderl, Stefan
    O'Brien, Susan M.
    Konopleva, Marina
    Ferrajoli, Alessandra
    Kornblau, Steven M.
    Daver, Naval
    Pemmaraju, Naveen
    Bose, Prithviraj
    Thompson, Philip A.
    Kelly, Mary A.
    Garris, Rebecca
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    [J]. BLOOD, 2016, 128 (22)
  • [2] Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
    Abaza, Yasmin
    Kantarjian, Hagop M.
    Faderl, Stefan
    Jabbour, Elias
    Jain, Nitin
    Thomas, Deborah
    Kadia, Tapan
    Borthakur, Gautam
    Khoury, Joseph D.
    Burger, Jan
    Wierda, William
    O'Brien, Susan
    Konopleva, Marina
    Ferrajoli, Alessandra
    Kebriaei, Partow
    Dabaja, Bouthaina
    Kornblau, Steven
    Alvarado, Yesid
    Daver, Naval
    Pemmaraju, Naveen
    Bose, Prithviraj
    Thompson, Philip
    Al Azzawi, Hind
    Kelly, Mary R. N.
    Garris, Rebecca
    Jain, Preetesh
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Ravandi, Farhad
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) : 91 - 99
  • [3] Phase II Study of Nelarabine with Hyper-CVAD in Patients with Previously Untreated T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL)
    Jain, Preetesh
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Ravandi, Farhad
    Kadia, Tapan M.
    Burger, Jan A.
    Borthakur, Gautam
    Cortes, Jorge E.
    Daver, Naval
    Jabbour, Elias J.
    Koller, Charles Asa
    Konopleva, Marina
    Pemmaraju, Naveen
    Kelly, Marry A.
    Garris, Rebecca
    O'Brien, Susan
    Faderl, Stefan
    [J]. BLOOD, 2012, 120 (21)
  • [4] SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma
    Kwong, YL
    Chan, D
    Liang, R
    [J]. CANCER GENETICS AND CYTOGENETICS, 1995, 85 (02) : 159 - 160
  • [5] The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience
    P Jain
    H Kantarjian
    F Ravandi
    D Thomas
    S O'Brien
    T Kadia
    J Burger
    G Borthakur
    N Daver
    E Jabbour
    M Konopleva
    J Cortes
    N Pemmaraju
    M A Kelly
    M Cardenas-Turanzas
    R Garris
    S Faderl
    [J]. Leukemia, 2014, 28 : 973 - 975
  • [6] The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience
    Jain, P.
    Kantarjian, H.
    Ravandi, F.
    Thomas, D.
    O'Brien, S.
    Kadia, T.
    Burger, J.
    Borthakur, G.
    Daver, N.
    Jabbour, E.
    Konopleva, M.
    Cortes, J.
    Pemmaraju, N.
    Kelly, M. A.
    Cardenas-Turanzas, M.
    Garris, R.
    Faderl, S.
    [J]. LEUKEMIA, 2014, 28 (04) : 973 - 975
  • [7] Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL) with Hypercvad Based Regimens
    Jain, Preetesh
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Kanagal-Shamanna, Rashmi
    Khoury, Joseph D.
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Jain, Nitin
    Sasaki, Koji
    Kadia, Tapan M.
    Borthakur, Gautam
    Garris, Rebecca
    Pierce, Sherry
    Estrov, Zeev
    Wierda, William G.
    Cortes, Jorge E.
    O'Brien, Susan M.
    Jabbour, Elias J.
    [J]. BLOOD, 2016, 128 (22)
  • [8] Hyper-CVAD-Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia
    Jabbour, Elias J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (09) : 547 - 549
  • [9] Comparison of Biological Characteristics and Outcomes of T-Acute Lymphoblastic Leukemia and T-Lymphoblastic No Hodgkin Lymphoma in Patients who Received High Dose Methotrexate
    Bertone, M. C.
    Bernasconi, A.
    Galluzo, M. L.
    Solernou, V.
    Guitter, M.
    Sanchez La Rosa, C.
    Millan, N.
    Alfaro, E.
    Rossi, J.
    Felice, M. S.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 : S103 - S103
  • [10] Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.
    Thomas, Deborah A.
    O'Brien, Susan
    Rytting, Michael
    Faderl, Stefan
    Cortes, Jorge
    Wierda, William G.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    [J]. BLOOD, 2008, 112 (11) : 674 - 674
12345